Stocks closed lower Wednesday after the Federal Reserve left its key interest rate unchanged amid persistent inflation, as investors prepared for a slew of earnings reports from major technology companies.

P&G is a unique Dividend King because it uses both buybacks and dividends to return capital to shareholders. A Dividend King like Coca-Cola may yield more than P&G, but it doesn't consistently buy back stock.

The Dow Jones sold off Monday as Nvidia stock plunged on an artificial intelligence threat from China known as DeepSeek.

The US indices look solid in the early hours of Wednesday, a day that will feature the Federal Reserve announcement on interest rates, and monetary policy later in the day.

Stocks were sharply lower Monday afternoon on concerns about the competitive threat that China poses in the race to develop artificial intelligence.

Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend stocks stand out as the best buys right now.

Investors should take note of management's commentary on these underperforming regions in the upcoming earnings call. Economic challenges and currency headwinds are eroding the company's pricing power in these underperforming regions. So, any improvement would go a long way for the broader business.

The Dow Jones Industrial Average, or simply the Dow, is one of the most well-known and influential stock market indices globally.

UnitedHealth is putting pressure on the 30-stock index Thursday after the insurance giant reported a rare revenue miss. This is what you need to know.

Monday's tech rout has brought no shortage of big numbers on Wall Street, and here's another to keep in mind: $441.9 billion. That's the amount of market capitalization that Nvidia has shed, based on intraday activity.

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a look at where 3M Company (NYSE:MMM) stands against the other high yield

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's shares had meant it recently ceded that title to French luxury conglomerate LVMH.